Sunday, August 31, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Buy Rating for Geron with 4 Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Tech-banking-finance
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Needham analyst Gil Blum has once again expressed optimism for Geron (NASDAQ: GERN), reiterating a Buy rating and holding steady with a $4 price target. This reaffirmation of confidence in the stock‘s potential is in line with previous reports from Needham, highlighting a strong belief in Geron’s future success. The consensus among analysts remains overwhelmingly positive, with 4 stock analysts, including Needham, giving Geron a “Strong Buy” rating. This consistent show of support underscores a bright outlook for Geron’s performance and growth opportunities in the market.

Date: March 4, 2024

Geron Corporation (GERN) Stock Surges 13% on March 4, 2024: Positive Momentum Continues in Pre-Market Trading

On March 4, 2024, Geron Corporation (GERN) saw a significant increase in its stock performance. The price of GERN shares experienced a notable increase of $0.26 since the market last closed, representing a 13.00% rise from its previous closing price of $2.26. Additionally, in pre-market trading, the stock has continued to rise, with an additional $0.09 increase. This positive price momentum for GERN may be attributed to various factors such as positive news announcements, favorable market conditions, or increased investor confidence in the company’s prospects. Investors and analysts will likely be monitoring the stock closely to see if this upward trend continues throughout the trading day. Investors will be watching closely to see how the stock performs in the coming days and weeks.

Geron Corporation (GERN) Reports Decline in Revenue and Net Income for 2024, But Shows Improvement in Earnings Per Share

On March 4, 2024, Geron Corporation (GERN) saw a decline in its stock performance following the release of its financial results. The company reported a total revenue of $237.00K for the past year, marking a significant decrease of 60.23% compared to the previous year. Additionally, the total revenue for the last quarter was reported at $23.00K, showing a staggering decline of 85.98% since the previous quarter.

In terms of net income, Geron Corporation reported a net loss of -$184.13M for the past year, representing a decrease of 29.76% compared to the previous year. The net loss for the last quarter was reported at -$51.97M, marking a decrease of 16.0% since the previous quarter.

Despite the declines in total revenue and net income, Geron Corporation did see a slight improvement in its earnings per share (EPS) performance. The company reported an EPS of -$0.32 for the past year, which was an increase of 13.39% compared to the previous year. The EPS for the last quarter was reported at -$0.09, showing no change since the previous quarter.

Overall, the financial results released by Geron Corporation on March 4, 2024, reflected a challenging period for the company with declines in total revenue and net income. However, the slight improvement in EPS may provide some optimism for investors moving forward.

Tags: GERN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Stock Bull Market

Analysts Bullish on Costco Wholesale Price Targets and Ratings

Biotechnology Stock Exchange

Durect Corporation and Charles River Laboratories Announce Partnership for Alzet Osmotic Pumps

FLO stock news

Baird Analyst Maintains Neutral Rating on MasTec with Raised Price Target

Recommended

The Rise of Liquid Staking: How Validator-Specific Tokens Are Reshaping DeFi

Analyst Reiterates Neutral Rating for Perficient with Increased Price Target

2 years ago
Murphy Oil Stock

Major Investors Divided on Murphy Oil’s Prospects

2 weeks ago
Afterpay_for_Your_Amazon

Unlock the Benefits: How to Use Afterpay for Your Amazon Purchases

2 years ago
MKS Instruments Stock

MKS Instruments: Dividend Payment Highlights Strategic Crossroads

6 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAL AAPL Adobe ADSK AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DIS DWAC Eli Lilly GM IBM INTC Intel Kraft Heinz LLY Lockheed META Micron MP Materials MSFT NFLX NIO NVO Opendoor Oracle Palantir PayPal PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Final Distribution Marks Essa Pharma’s Corporate Dissolution

Shareholder Revolt Sparks Sharp Decline for Yellow Corporation Stock

Institutional Investors Rally Behind Amicus Therapeutics Stock

Mixed Signals: Haemonetics Beats Estimates Yet Faces Analyst Skepticism

Oramed’s Liquidity Challenge: A Profit Masking Deeper Financial Strain

BridgeBio’s Cardiovascular Breakthrough Fuels Investor Confidence

Trending

MSCI World ETF Stock
ETF

The MSCI World ETF’s Growing Reliance on a Handful of US Tech Stocks

by Felix Baarz
August 31, 2025
0

The iShares MSCI World ETF, designed to mirror the performance of developed economies worldwide, is increasingly influenced...

Health Catalyst Stock

Health Catalyst: A Tale of Conflicting Market Sentiment

August 31, 2025
Beauty Health Co Stock

Beauty Health Stock: A Tale of Conflicting Market Signals

August 31, 2025
Essa Stock

Final Distribution Marks Essa Pharma’s Corporate Dissolution

August 31, 2025
Yellow Stock

Shareholder Revolt Sparks Sharp Decline for Yellow Corporation Stock

August 31, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • The MSCI World ETF’s Growing Reliance on a Handful of US Tech Stocks August 31, 2025
  • Health Catalyst: A Tale of Conflicting Market Sentiment August 31, 2025
  • Beauty Health Stock: A Tale of Conflicting Market Signals August 31, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com